Physiological functions of endoplasmic reticulum stress transducer OASIS in central nervous system

In humans, there are more than 55 known basic leucine zipper (bZIP) transcription factors (Newman and Keating 2003). By sequence similarity in the coiled-coil region, these transcription factors can be divided into 16 different families. Recently, novel types of ER stress transducers, i.e., ER membrane-bound bZIP transcription factors that share a region of high sequence similarity with ATF6, have been identified. They have a transmembrane domain that allows them to associate with the ER, and possess both a transcription-activation domain and a bZIP domain. The new types of ER stress transducers include OASIS (Kondo et al. 2005; Murakami et al. 2009), BBF2H7 (Kondo et al. 2007; Saito et al. 2009), CREBH (Omori et al. 2001; Zhang et al. 2006), CREB4 (Qi et al. 2002; Cao et al. 2002; Adham et al. 2005; Nagamori et al. 2005), and Luman (Lu et al. 1997; DenBoer et al. 2005; Liang et al. 2006) (Fig. 2). Interestingly, each of them commonly contains the consensus sequence for cleavage by site-1 protease (S1P) and site-2 protease (S2P) in its luminal segment, indicating that they are processed at transmembrane regions by regulated intramembrane proteolysis (RIP) (Ye et al. 2000; Bailey and O’Hare 2007). Their cleaved N-terminal fragments translocate into the nucleus to act as transcription factors. In this review, these bZIP transmembrane transcription factors are referred to as OASIS family members. Despite structural similarities among these proteins and ATF6, differences in activating stimuli and tissue distribution indicate that these proteins play specific roles in regulating the UPR signaling in specific organs and tissues. OASIS, BBF2H7, CREBH, and CREB4 are expressed preferentially in osteoblasts and astrocytes (Kondo et al. 2005; Murakami et al. 2009), chondrocytes (Saito et al. 2009), liver cells (Omori et al. 2001), and prostate and testis (Cao et al. 2002), respectively. The Luman transcript is present in a wide range of adult and fetal tissues (Lu et al. 1997), but its translated product has been found only in trigeminal ganglional neurons and monocytes, and dendritic cells (DCs) (Lu and Misra 2000; Ko et al. 2004; Eleveld-Trancikova et al. 2010). Evolutionarily, orthologues of ATF6 and OASIS family proteins exist in organisms higher than Caenorhabditis  elegans. C. elegans contains three bZIP transcription factors. Although the degree of homology is less than those in the mammalian family, these proteins are related most closely to ATF6, OASIS and Luman (Shen et al. 2005; Fox et al. 2010). In Drosophila, two bZIP transcription factors are related most closely to ATF6 and OASIS (Fox et al. 2010). In vertebrates, cells are diversely differentiated to play proper roles for various biological phenomena, and also adapt to environmental parameters. Vertebrate cells adjust the functionality and capacity of their ER depending on the diversity of cell types. Thus, the signaling of the vertebrate UPR, which is regulated by canonical ER stress transducers and OASIS family members, has considerable complexity and is highly developed in cell-type specific patterns. This review is focused on the current understanding of the biological characteristics and physiological functions of OASIS in the central nervous system (CNS).

The Oasis gene was originally identified as a gene specifically induced in long-term cultured astrocytes (Honma et al. 1999). The OASIS protein is a bZIP transcription factor of the cyclic AMP-response element (CRE)-binding protein (CREB)/ATF family, with a transmembrane domain that allows it to associate with the ER. Its N-terminus containing the transmembrane domain is 31 % identical to ATF6, but its C-terminus, which is within the ER lumen, does not show homology to ATF6. In the luminal segment, OASIS contains the sequence RSLL (beginning at residue 423), which fits the RxxL consensus for S1P whose active site faces the Golgi lumen. Indeed, under ER stress conditions, OASIS is cleaved at the site by S1P and subsequently at the transmembrane domain by S2P (Kondo et al. 2005; Murakami et al. 2006). The cleaved N-terminus containing transcription-activation domain and bZIP domain translocates into the nucleus to act as a transcription factor through the binding to the CRE sequence (Fig. 3). ATF6 contains a stretch of amino acid sequence in its luminal domain that is essential for translocation from the ER to the Golgi apparatus (Shen et al. 2002). However, translocation to the Golgi apparatus and proteolytic processing are intact in all deletion mutants for the luminal domain of OASIS, indicating that OASIS does not have significant sequences for Golgi localization signaling (Murakami et al. 2006). Therefore, the translocation system from the ER to the Golgi apparatus is quite different between OASIS and ATF6 under ER stress conditions. Under normal conditions, ATF6 is bound constitutively by an ER-resident chaperone BiP in its luminal domain and rendered inactive (Shen et al. 2002; Chen et al. 2002). Accumulation of unfolded proteins in the ER results in the dissociation of BiP from the luminal domain of ATF6 and then ATF6 is translocated to the Golgi apparatus. The ER luminal domain of OASIS does not possess the sensing function for unfolded proteins. OASIS is degraded easily under normal conditions via the ubiquitin–proteasome pathway (Kondo et al. 2012). An ER stress condition enhances the stability of OASIS. The stabilized OASIS is transported automatically from the ER to the Golgi apparatus and is then cleaved to generate N-terminus by RIP. Thus, the ER stress-sensing function is not necessary in the ER luminal domain of OASIS for its activation.

Oasis is highly expressed in osteoblasts of osseous tissues (Murakami et al. 2009) and astrocytes of the CNS (Kondo et al. 2005; Chihara et al. 2009), and to considerable levels in intestine, salivary glands, and prostate (Honma et al. 1999; Omori et al. 2002; Asada et al. 2012). In C6 glioma cell lines and primary cultured osteoblasts, Oasis is induced at the transcriptional level after treatment with ER stressors such as tunicamycin or thapsigargin (Kondo et al. 2005). Oasis deficient (Oasis ^−/−) mice are born at the expected Mendelian ratios, but the mice exhibit severe osteopenia involving a decrease in bone density at all skeletal sites and spontaneous fractures (Murakami et al. 2009). From detailed analyses on gene expression in Oasis ^−/− bones, Type I collagen (Col1)—a major component of osseous tissues—was identified as one of the targets for OASIS. OASIS activates the transcription of Col1 through direct binding to a CRE-like sequence that exists in the Col1 promoter regions. Indeed, Oasis ^−/− osseous tissues show a significant decrease in the amounts of type I collagen. The defect of bone formation involving decreased amounts of type I collagen is rescued completely by osteoblast-specific overexpression of OASIS, indicating that osteopenia in Oasis ^−/− mice is caused primarily by deletion of Oasis and its target, Col1 gene in osteoblasts (Murakami et al. 2010).

As mentioned above, Oasis is also highly expressed in astrocytes of the CNS. OASIS is up-regulated in reactive astrocytes after neuronal degeneration induced by kainic acid (KA). In hippocampal astrocytes injured by intraperitoneal injection of KA, ER stress is induced and Oasis mRNA is strongly up-regulated (Chihara et al. 2009). Pyramidal neurons in the hippocampi of Oasis ^−/− mice are more susceptible to the toxicity induced by KA than those of wild-type (WT) mice. The number of glial fibrillary acidic protein (GFAP)-positive reactive astrocytes, an astrocyte marker, was decreased in the hippocampi of Oasis ^−/− mice compared with those of WT mice after brain injury. In embryonic stages, Oasis mRNA is barely observed in the cerebral cortices of embryonic day (E) 14.5 mice; however, strong signals are detected at E16.5 and E18.5 (Saito et al. 2012), coinciding with the initiation of extensive differentiation of neural precursor cells (NPCs) into astrocytes. Oasis ^−/− mice exhibit impaired astrocyte differentiation in embryonic stages. The numbers of cells positive for GFAP are significantly higher in the cerebral cortices of WT mice than in those of Oasis ^−/− mice at E18.5 (Fig. 4a, b) (Saito et al. 2012). By contrast, those of nestin—an NPC marker—are higher in the cerebral cortices of Oasis ^−/− mice than in those of WT mice at E18.5 (Fig. 4c, d). The impaired astrocyte differentiation is also observed in primary cultured NPCs prepared from E14.5 Oasis ^−/− mice telencephalons. In primary cultured Oasis ^−/− NPCs treated with leukemia inhibitory factor (LIF) and bone morphogenetic protein 2 (BMP2), which promote the differentiation of NPCs into astrocytes (Bonni et al. 1997; Nakashima et al. 1999a, b) (Fig. 4e), the induction of Gfap expression and the reduction of Nestin expression are significantly inhibited compared with those of WT cells (Fig. 4f).

Glial Cell Missing 1 (Gcm1) is identified as a target of OASIS. OASIS promotes the expression of Gcm1 through the binding to the CRE-like sequence in the promoter region of Gcm1 in CNS and trophoblasts (Schubert et al. 2008; Saito et al. 2012). The Gcm1 Drosophila ortholog, gcm, has been reported to control neuronal and glial fates (Hosoya et al. 1995; Jones et al. 1995; Vincent et al. 1996). In mammalian cells, the introduction of Gcm1 into cultured brain cells derived from mice induced the astrocyte lineage (Iwasaki et al. 2003). As described above, Gcm1 is critical for astrocyte differentiation; however, the detailed mechanisms regulating differentiation have not been defined. It is well known that the activation of Stat3 and Smads, and epigenetic regulation of the methylation status of the Gfap promoter, are essential for the differentiation of NPCs into astrocytes. Phosphorylated-Stat3 and Smads bind to demethylated sites in the Gfap promoter to form a Stat3-Smads-p300 complex and promote transcription of Gfap (Bonni et al. 1997; Nakashima et al. 1999a, b, Takizawa et al. 2001). Although the levels of phosphorylated Stat3 and Smads are not changed, the amount of demethylation of the Gfap promoter is decreased significantly in Oasis ^−/− NPCs compared with those of WT NPCs (Saito et al. 2012). Thus, the delayed astrocyte differentiation in Oasis ^−/− cells is caused by inhibition of demethylation of the Gfap promoter (Fig. 5). The mammalian homologs of gcm are Gcm1 and Gcm2. These molecules show little homology and have no common functional domains except for the GCM-motif (Akiyama et al. 1996). Previous report have shown that both have the potential to accelerate demethylation of the Hes5 promoter by direct binding to the GCM-binding site in the promoter followed by acquiring stem cell properties, but Gcm2 is a more crucial factor than Gcm1 for demethylation of the Hes5 promoter because of the lower expression of Hes5 in Gcm2 ^−/− mice than in Gcm1 ^−/− mice (Hitoshi et al. 2011). The expression of Gcm1 is significantly up-regulated at later stages of mouse embryonic development, whereas that of Gcm2 is transiently up-regulated at the early stage (Hitoshi et al. 2011). Therefore, we presume that Gcm2 is involved mainly in demethylation of the Hes5 promoter at the early stage of mouse embryonic development and, conversely, that Gcm1 mainly plays a role in the demethylation of the Gfap promoter in the late stage. The distinct expression patterns and target promoters for demethylation between Gcm1 and Gcm2 may determine glial and neuronal cell lineages, respectively.

The bZIP type transcription factors including OASIS family members are known to form homodimers or heterodimers to promote transcription (Hai and Hartman 2001; Zhang et al. 2006). During astrocyte differentiation, not only OASIS but also CREB4 and Luman regulate the transcription of Gcm1 (Saito et al. 2012). OASIS and CREB4 N-termini form heterodimers and activate transcription of Gcm1 during astrocyte differentiation. Conversely, the Luman N-terminus inhibits the formation of the OASIS-CREB4 heterodimer by binding to the OASIS N-terminus and down-regulating transcription of Gcm1, leading to a cessation of astrocyte differentiation (Fig. 6). Therefore, dynamic interactions among OASIS, CREB4 and Luman regulate the spatio-temporal expression of Gcm1 during astrocyte differentiation. These OASIS family members activate UPR signaling in response to physiological ER stress to fine-tune the expression of Gcm1 followed by regulating astrocyte differentiation. UPR signaling activated by physiological ER stress is known to be crucial for the differentiation of secretory cells including osteoblasts (Murakami et al. 2009; Saito et al. 2011; Tohmonda et al. 2011), chondrocytes (Saito et al. 2009), and plasma cells (Gass et al. 2002; Iwakoshi et al. 2003). During the differentiation of progenitor cells into these mature secretory cells, secretory materials are gradually produced, and abundant nascent proteins are delivered to the ER. Such an event may serve as a trigger for physiological ER stress. Astrocytes also synthesize and secrete various neurotrophic factors and cytokines. Physiological ER stress caused by production of abundant secretory proteins could be activated during differentiation of NPCs into mature astrocytes. OASIS, CREB4 and Luman may be activated as transcription factors in response to this physiological ER stress. The difference between physiological and pathological ER stress remains unclear. Treatment of NPCs with low doses of several ER stressors, including tunicamycin and dithiothreitol, promotes the differentiation of NPCs into astrocytes but not apoptosis (Saito et al. 2012). Thus, physiological and pathological ER stress may be distinguished, in part, only by the difference of the burden levels on the ER. Additionally, recent studies have shown that ER stress transducers can mildly activate ER stress-independent phenomena such as changes in the lipid-constitution of the ER membrane (Volmer et al. 2013). It is possible that not only mild ER stress, which does not promote apoptosis, but also ER stress-independent phenomena may activate ER stress transducers in the same was as physiological ER stress during cell differentiation.